February 10, 2010 / 12:51 PM / 8 years ago

UPDATE 1-MDS to sell pharma services unit

* To sell pharma services unit for $45 mln to Ricerca

* Sale price includes $25 mln note, $20 mln in cash

TORONTO, Feb 10 (Reuters) - MDS Inc MDS.TO said on Wednesday that Ricerca Biosciences would buy its business that provides clinical trial services to biotech and pharmaceutical companies for $45 million and certain minority equity interests.

The Toronto-based company said following this sale of its pharma services early-stage business, it will have completed its planned divestitures, allowing it to focus on its Nordion division — a supplier of medical isotopes for molecular imaging, radiotherapeutics and sterilization technologies.

In September, the company announced plans to sell its analytical tools division to U.S.-based Danaher Corp (DHR.N) for $650 million. [ID:nN02528673]

MDS said the $45 million sale price for the pharma services business included a five-year $25 million note and $20 million in cash that will be adjusted for working capital and other items. (Reporting by Euan Rocha; Editing by Lisa Von Ahn)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below